Harry Perkins Institute of Medical Research

Venom from honeybees found to kill aggressive breast cancer cells

Research published in Nature Precision Oncology reveals that honeybee venom and its compound melittin rapidly destroy triple-negative and HER2-enriched breast cancer cells. The venom's potency allows for selective cell death with minimal effects on normal cells.

SourceHarry Perkins Institute of Medical Research·Journalnpj Precision Oncology·DateSep 1, 2020

Common medicine used to treat gout found to prevent progression of coronary disease

A large Australian-Dutch trial confirmed low-dose colchicine significantly reduced cardiovascular death, heart attack, and stroke in patients with chronic coronary disease. Colchicine was safe and well-tolerated over the long-term, making it a potential cornerstone treatment alongside aspirin and statins.

SourceHarry Perkins Institute of Medical Research·JournalNew England Journal of Medicine·DateAug 31, 2020